IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Saroja Pharma Industries India IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Chemical - Speciality sector. Swastika Investmart is the merchant banker of Saroja Pharma Industries India IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th June 2023.
Saroja Pharma Industries India IPO open date is 31st August 2023 and close date is 5th September 2023. IPO Allotment Date is 8th September 2023 and Listing date is 13th September 2023.Saroja Pharma Industries India IPO size is Rs 9.11 Cr. crores with IPO price of Rs 84.00 Cr.. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Swastika Investmart Limited is the book-running lead manager of the Saroja Pharma Industries India IPO. Kfin Technologies Limited is the Registrar and Market Maker is Swastika Investmart Limited for Saroja Pharma Industries India IPO.
Saroja Pharma Industries India IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Saroja Pharma Industries India IPO, based in Mumbai, operates in the Chemical - Speciality sector with a focus on Pharmaceutical and healthcare. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Saroja Pharma Industries India IPO size is ₹ 9.11 Cr. Crores with fresh issue size of Rs 9.11 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Saroja Pharma Industries India IPO is expected to be 8th September 2023, after the finalization of basis of allotment. Investors can check Saroja Pharma Industries India IPO allotment status on the registrars website, Kfin Technologies Limited. Saroja Pharma Industries India IPO refund dates are 11th September 2023.
Saroja Pharma Industries India IPO is expected to be listed on 13th September 2023.
The upper price band for the Saroja Pharma Industries India IPO is set at ₹ 84.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Saroja Pharma Industries India IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Saroja Pharma Industries India IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 5th September 2023. After submission, funds are blocked until the basis of allotment of Saroja Pharma Industries India IPO is finalised.
The merchant banker for Saroja Pharma Industries India IPO is Swastika Investmart Limited . Swastika Investmart Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Saroja Pharma Industries India IPO RHP for further details.
The registrar for Saroja Pharma Industries India IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Saroja Pharma Industries India IPO through their official website or helpline.
Saroja Pharma Industries India IPO was subscribed 8.88 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 9.11 Cr.
Avg IPO Size (Sector Based)
:
₹ 23.03 Cr.
Sector: Chemical - Speciality
SME IPO so far:
7
Merchant Banker:
Swastika Investmart
SME IPO by BRLM so far:
47
City:
Mumbai
SME IPO so far:
280
Revenue (annualised):
₹ 50.35 cr.
PE
Ratio:
23.27x
Average Sector PE Ratio: 15.57x
Saroja Pharma Industries India IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Saroja Pharma Industries India Financial Review Page
Merchant Banker(s) of Saroja Pharma Industries India IPO: Swastika Investmart Limited
Saroja Pharma Industries India IPO subscription was 8.88 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Saroja Pharma Industries India IPO listed at a listing price of 68.25 against the offer price of 84.00.
The current market price of Saroja Pharma Industries India is 45.50.
Why Us?
